These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 18209454)
1. L-carnitine supplementation in hemodialysis patients. Mitwalli AH; Al-Wakeel JS; Alam A; Tarif N; Abu-Aisha H; Rashed M; Al Nahed N Saudi J Kidney Dis Transpl; 2005; 16(1):17-22. PubMed ID: 18209454 [TBL] [Abstract][Full Text] [Related]
2. The evaluation of postdialysis L-carnitine administration and its effect on weekly requiring doses of rHuEPO in hemodialysis patients. Kadiroglu AK; Yilmaz ME; Sit D; Kara IH; Isikoglu B Ren Fail; 2005; 27(4):367-72. PubMed ID: 16060121 [TBL] [Abstract][Full Text] [Related]
3. Effect of dialysate composition on the lipid response to L-carnitine supplementation. Zilleruelo G; Novak M; Hsia SL; Goldberg R; Abitbol C; Monkus E; Strauss J Kidney Int Suppl; 1989 Nov; 27():S259-63. PubMed ID: 2699997 [TBL] [Abstract][Full Text] [Related]
4. The effects of L-carnitine therapy on respiratory function tests in chronic hemodialysis patients. Bavbek N; Akay H; Uz B; Uz E; Turgut F; Kanbay M; Senes M; Akcay A; Duranay M Ren Fail; 2010 Jan; 32(2):157-61. PubMed ID: 20199175 [TBL] [Abstract][Full Text] [Related]
5. The effect of L-carnitine supplementation on lipid parameters, inflammatory and nutritional markers in maintenance hemodialysis patients. Suchitra MM; Ashalatha VL; Sailaja E; Rao AM; Reddy VS; Bitla AR; Sivakumar V; Rao PV Saudi J Kidney Dis Transpl; 2011 Nov; 22(6):1155-9. PubMed ID: 22089773 [TBL] [Abstract][Full Text] [Related]
6. Effect of L-carnitine on the serum lipoproteins and HDL-C subclasses in hemodialysis patients. Argani H; Rahbaninoubar M; Ghorbanihagjo A; Golmohammadi Z; Rashtchizadeh N Nephron Clin Pract; 2005; 101(4):c174-9. PubMed ID: 16103722 [TBL] [Abstract][Full Text] [Related]
7. The role of oral L-carnitine therapy in chronic hemodialysis patients. Sabry AA Saudi J Kidney Dis Transpl; 2010 May; 21(3):454-9. PubMed ID: 20427868 [TBL] [Abstract][Full Text] [Related]
8. Effects of l-carnitine supplement on serum amyloid A and vascular inflammation markers in hemodialysis patients: a randomized controlled trial. Tabibi H; Hakeshzadeh F; Hedayati M; Malakoutian T J Ren Nutr; 2011 Nov; 21(6):485-91. PubMed ID: 21439850 [TBL] [Abstract][Full Text] [Related]
9. The influence of l-carnitine supplementation on hematocrit and hemoglobin levels in patients with end stage renal failure on CAPD. Sotirakopoulos N; Athanasiou G; Tsitsios T; Mavromatidis K Ren Fail; 2002 Jul; 24(4):505-10. PubMed ID: 12212830 [TBL] [Abstract][Full Text] [Related]
10. Oral carnitine supplementation for dyslipidemia in chronic hemodialysis patients. Naini AE; Sadeghi M; Mortazavi M; Moghadasi M; Harandi AA Saudi J Kidney Dis Transpl; 2012 May; 23(3):484-8. PubMed ID: 22569432 [TBL] [Abstract][Full Text] [Related]
11. Effect of intravenous iron saccharate on the requirements of erythropoietin in hemodialysis patients. Shaheen FA; Souqiyyeh MZ; Akeel N Saudi J Kidney Dis Transpl; 2002; 13(2):131-40. PubMed ID: 17660651 [TBL] [Abstract][Full Text] [Related]
12. The effects of zinc supplementation on serum zinc and cholesterol concentrations in hemodialysis patients. Chevalier CA; Liepa G; Murphy MD; Suneson J; Vanbeber AD; Gorman MA; Cochran C J Ren Nutr; 2002 Jul; 12(3):183-9. PubMed ID: 12105816 [TBL] [Abstract][Full Text] [Related]
13. Effects of L-carnitine supplement on serum inflammatory cytokines, C-reactive protein, lipoprotein (a), and oxidative stress in hemodialysis patients with Lp (a) hyperlipoproteinemia. Shakeri A; Tabibi H; Hedayati M Hemodial Int; 2010 Oct; 14(4):498-504. PubMed ID: 20812958 [TBL] [Abstract][Full Text] [Related]
14. The effects of L-carnitine on respiratory function tests in children undergoing chronic hemodialysis. Kavukçu S; Türkmen M; Salman S; Onvural B; Oktay G; Karaman O; Cevik NT Turk J Pediatr; 1998; 40(1):79-84. PubMed ID: 9673532 [TBL] [Abstract][Full Text] [Related]
15. Serum erythropoietin levels and their correlation with the erythropoietic system in hemodialysis patients and renal allograft recipients. Khosroshahi HT; Shoja MM; Tubbs RS; Estakhri R; Ardalan MR Transplant Proc; 2007 May; 39(4):1051-3. PubMed ID: 17524889 [TBL] [Abstract][Full Text] [Related]
16. [Effect of erythropoietin therapy on serum lipoprotein levels in patients on hemodialysis]. Kes P; Bobić I; Reiner Z; Ratković-Gusić I Lijec Vjesn; 2002 May; 124(5):146-50. PubMed ID: 12152415 [TBL] [Abstract][Full Text] [Related]
17. L-carnitine use in dialysis patients: is national coverage for supplementation justified? What were CMS regulators thinking--or were they? Steinman TI; Nissenson AR; Glassock RJ; Dickmeyer J; Mattern WD; Parker TF; Hull AR Nephrol News Issues; 2003 Apr; 17(5):28-30, 32-4, 36 passim. PubMed ID: 12715624 [TBL] [Abstract][Full Text] [Related]
18. The effects of GH replacement therapy on cardiac morphology and function, exercise capacity and serum lipids in elderly patients with GH deficiency. Elgzyri T; Castenfors J; Hägg E; Backman C; Thorén M; Bramnert M Clin Endocrinol (Oxf); 2004 Jul; 61(1):113-22. PubMed ID: 15212653 [TBL] [Abstract][Full Text] [Related]
19. The effects of L-carnitine supplementation on performance during interval swimming. Trappe SW; Costill DL; Goodpaster B; Vukovich MD; Fink WJ Int J Sports Med; 1994 May; 15(4):181-5. PubMed ID: 8063466 [TBL] [Abstract][Full Text] [Related]